The commitment to biosimilar medicines translates into savings of more than 1.000 million euros annually

Encarna Cruz, general director of BioSim, has been the new guest on the Asefarma video podcasts. In her participation, she reviewed the most relevant utilization and efficiencies figures for the use of biosimilar medicines in Spain, in addition to commenting on the Association's role as a promoter of activities and information of interest to professionals, patients and health administration.

READ MORE